Filing Details

Accession Number:
0001171843-15-003459
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-06-16 17:02:57
Reporting Period:
2015-06-15
Filing Date:
2015-06-16
Accepted Time:
2015-06-16 17:02:57
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
722830 Immunomedics Inc IMMU In Vitro & In Vivo Diagnostic Substances (2835) 611009366
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1202016 L Cynthia Goldenberg C/O Immunomedics, Inc.
300 American Road
Morris Plains NJ 07950
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-06-15 70,297 $1.75 579,854 No 4 M Direct
Common Stock Disposition 2015-06-15 38,248 $4.12 541,606 No 4 S Direct
Common Stock Acquisiton 2015-06-15 150,000 $1.75 5,431,417 No 4 M Indirect See footnote
Common Stock Disposition 2015-06-15 82,077 $4.07 5,349,340 No 4 S Indirect See footnote
Common Stock Acquisiton 2015-06-15 120,050 $2.67 5,469,390 No 4 M Indirect See footnote
Common Stock Disposition 2015-06-15 90,666 $4.07 5,378,724 No 4 S Indirect See footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Indirect See footnote
No 4 S Indirect See footnote
No 4 M Indirect See footnote
No 4 S Indirect See footnote
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock, Par Value $0.01 Per Share Stock Option (right to buy) Acquisiton 2015-06-15 70,297 $0.00 70,297 $1.75
Common Stock, Par Value $0.01 Per Share Stock Option (right to buy) Acquisiton 2015-06-15 150,000 $0.00 150,000 $1.75
Common Stock, Par Value $0.01 Per Share Stock Option (right to buy) Acquisiton 2015-06-15 120,050 $0.00 120,050 $2.67
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2015-06-15 No 4 M Direct
0 2015-06-15 No 4 M Indirect
0 2015-07-18 No 4 M Indirect
Footnotes
  1. Includes a total of 190,000 shares held as joint tenants by the reporting person and her spouse, David M. Goldenberg, the Issuer's Chief Scientific Officer and Chairman of the Board of Directors.
  2. The price in column 4 is a weighted average price. The prices actually received in this transaction range from $4.09 to $4.16.
  3. The reporting person has provided to the issuer, and the issuer will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range reported.
  4. Such shares are held by the reporting person's spouse, by various trusts established for the benefit of the reporting person and/or family members of the reporting person, or by a majority-owned subsidiary of the Issuer, of which the reporting person is an officer. The reporting person disclaims beneficial ownership of these shares except to the extent of her pecuniary interests therein.
  5. The price in column 4 is a weighted average price. The prices actually received in this transaction range from $4.03 to $4.1625.
  6. The reporting person's spouse has provided to the issuer, and the issuer will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range reported.
  7. These stock options were granted pursuant to the Issuer's 2006 Stock Incentive Plan, and vested immediately.
  8. These stock options were granted pursuant to the Issuer's 2006 Stock Incentive Plan, and vested 25% on the first anniversary of the date of grant and 6.25% on a quarterly basis thereafter.
  9. The reporting person's spouse was granted these stock options pursuant to the Issuer's 2006 Stock Incentive Plan.